Sign Up to like & get
recommendations!
1
Published in 2017 at "Brain and Behavior"
DOI: 10.1002/brb3.737
Abstract: Continuous levodopa‐carbidopa intestinal gel (LCIG) diminishes daily “off” time and dyskinesia in patients with advanced Parkinson′s disease (PD). Complications are common with percutaneous endoscopic gastrostomy with a jejunal extension tube (PEG‐J).
read more here.
Keywords:
levodopa carbidopa;
carbidopa intestinal;
parkinson disease;
advanced parkinson ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Brain and Behavior"
DOI: 10.1002/brb3.848
Abstract: In Parkinson's disease (PD), effects on behavior and cognition of levodopa/carbidopa intestinal gel (LCIG) and subthalamic stimulation (STN‐DBS) and their practical consequences remain controversial. This study was designed to analyze the possible effects of these…
read more here.
Keywords:
intestinal gel;
stimulation;
carbidopa intestinal;
cognition behavior ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.12490
Abstract: In Parkinson’s disease (PD), dysphagia has a significant influence on nutritional status. When dysphagia is resistant to oral nutrition intervention, enteral nutrition using a percutaneous endoscopic gastrostomy (PEG) can be considered. A levodopa (L-DOPA)-carbidopa intestinal…
read more here.
Keywords:
endoscopic gastrostomy;
percutaneous endoscopic;
intestinal gel;
carbidopa intestinal ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.12509
Abstract: In Parkinson's disease, levodopa-carbidopa intestinal gel (LCIG) is indicated in control of motor fluctuations, dyskinesias1 and non-motor symptoms. We here report the first case of LCIG pediatric use. Our patient presented with upper limb tremor…
read more here.
Keywords:
levodopa carbidopa;
gel pediatric;
carbidopa intestinal;
intestinal gel ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.12701
Abstract: The levodopa carbidopa intestinal gel is a device‐assisted therapy used for the management of fluctuating motor symptoms of Parkinson's disease that are refractory to oral therapy. The approach has demonstrable clinical value, but consideration of…
read more here.
Keywords:
levodopa carbidopa;
manage patients;
patients levodopa;
carbidopa intestinal ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Internal Medicine Journal"
DOI: 10.1111/imj.13754
Abstract: Levodopa‐carbidopa intestinal gel (LCIG) is an effective treatment for Parkinson disease. Initiating therapy involves an initial naso‐jejunal (NJ) titration phase. The NJ phase is prolonged with significant morbidity. The aim of this study is to…
read more here.
Keywords:
levodopa carbidopa;
phase;
carbidopa intestinal;
naso jejunal ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Neurologia i neurochirurgia polska"
DOI: 10.5603/pjnns.a2023.0001
Abstract: Polyneuropathy (PNP) is a known complication of levodopa-carbidopa intestinal gel (LCIG) therapy of advanced Parkinson's Disease (PD). The overall prevalence of PNP in PD is estimated to be 42.1% (as shown in a review by…
read more here.
Keywords:
demyelinating polyneuropathy;
review;
levodopa carbidopa;
therapy ... See more keywords